These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 29182785)

  • 1. Antibiotic therapy in neonates and impact on gut microbiota and antibiotic resistance development: a systematic review.
    Fjalstad JW; Esaiassen E; Juvet LK; van den Anker JN; Klingenberg C
    J Antimicrob Chemother; 2018 Mar; 73(3):569-580. PubMed ID: 29182785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic exposure in neonates and early adverse outcomes: a systematic review and meta-analysis.
    Esaiassen E; Fjalstad JW; Juvet LK; van den Anker JN; Klingenberg C
    J Antimicrob Chemother; 2017 Jul; 72(7):1858-1870. PubMed ID: 28369594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative gut microbiota and resistome profiling of intensive care patients receiving selective digestive tract decontamination and healthy subjects.
    Buelow E; Bello González TDJ; Fuentes S; de Steenhuijsen Piters WAA; Lahti L; Bayjanov JR; Majoor EAM; Braat JC; van Mourik MSM; Oostdijk EAN; Willems RJL; Bonten MJM; van Passel MWJ; Smidt H; van Schaik W
    Microbiome; 2017 Aug; 5(1):88. PubMed ID: 28803549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Gram-negative-selective antibiotic that spares the gut microbiome.
    Muñoz KA; Ulrich RJ; Vasan AK; Sinclair M; Wen PC; Holmes JR; Lee HY; Hung CC; Fields CJ; Tajkhorshid E; Lau GW; Hergenrother PJ
    Nature; 2024 Jun; 630(8016):429-436. PubMed ID: 38811738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymyxin monotherapy or in combination against carbapenem-resistant bacteria: systematic review and meta-analysis.
    Zusman O; Altunin S; Koppel F; Dishon Benattar Y; Gedik H; Paul M
    J Antimicrob Chemother; 2017 Jan; 72(1):29-39. PubMed ID: 27624572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antibiotic pipeline for multi-drug resistant gram negative bacteria: what can we expect?
    Falagas ME; Mavroudis AD; Vardakas KZ
    Expert Rev Anti Infect Ther; 2016 Aug; 14(8):747-63. PubMed ID: 27400643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initial Gut Microbial Composition as a Key Factor Driving Host Response to Antibiotic Treatment, as Exemplified by the Presence or Absence of Commensal Escherichia coli.
    Ju T; Shoblak Y; Gao Y; Yang K; Fouhse J; Finlay BB; So YW; Stothard P; Willing BP
    Appl Environ Microbiol; 2017 Sep; 83(17):. PubMed ID: 28667114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotic perturbation of the preterm infant gut microbiome and resistome.
    Gasparrini AJ; Crofts TS; Gibson MK; Tarr PI; Warner BB; Dantas G
    Gut Microbes; 2016 Sep; 7(5):443-9. PubMed ID: 27472377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenatal and postnatal antibiotic exposure influences the gut microbiota of preterm infants in neonatal intensive care units.
    Zou ZH; Liu D; Li HD; Zhu DP; He Y; Hou T; Yu JL
    Ann Clin Microbiol Antimicrob; 2018 Mar; 17(1):9. PubMed ID: 29554907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of intrapartum antimicrobial prophylaxis upon the intestinal microbiota and the prevalence of antibiotic resistance genes in vaginally delivered full-term neonates.
    Nogacka A; Salazar N; Suárez M; Milani C; Arboleya S; Solís G; Fernández N; Alaez L; Hernández-Barranco AM; de Los Reyes-Gavilán CG; Ventura M; Gueimonde M
    Microbiome; 2017 Aug; 5(1):93. PubMed ID: 28789705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotics as both friends and foes of the human gut microbiome: The microbial community approach.
    Nogueira T; David PHC; Pothier J
    Drug Dev Res; 2019 Feb; 80(1):86-97. PubMed ID: 30370682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotics, obesity and the link to microbes - what are we doing to our children?
    Turta O; Rautava S
    BMC Med; 2016 Apr; 14():57. PubMed ID: 27090219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of antibiotic duration on the intestinal microbiota and resistome: The PIRATE RESISTANCE project, a cohort study nested within a randomized trial.
    Leo S; Lazarevic V; von Dach E; Kaiser L; Prendki V; Schrenzel J; Huttner BD; Huttner A
    EBioMedicine; 2021 Sep; 71():103566. PubMed ID: 34492446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of anti-Helicobacter pylori concomitant therapy and probiotic supplementation on the throat and gut microbiota in humans.
    Wang ZJ; Chen XF; Zhang ZX; Li YC; Deng J; Tu J; Song ZQ; Zou QH
    Microb Pathog; 2017 Aug; 109():156-161. PubMed ID: 28552806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotics and the developing infant gut microbiota and resistome.
    Gibson MK; Crofts TS; Dantas G
    Curr Opin Microbiol; 2015 Oct; 27():51-6. PubMed ID: 26241507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-day vs longer duration of antibiotic treatment for cystitis in women: systematic review and meta-analysis.
    Katchman EA; Milo G; Paul M; Christiaens T; Baerheim A; Leibovici L
    Am J Med; 2005 Nov; 118(11):1196-207. PubMed ID: 16271900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between antibiotics and gut microbiome dysbiosis in children: systematic review and meta-analysis.
    McDonnell L; Gilkes A; Ashworth M; Rowland V; Harries TH; Armstrong D; White P
    Gut Microbes; 2021; 13(1):1-18. PubMed ID: 33651651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic de-escalation for bloodstream infections and pneumonia: systematic review and meta-analysis.
    Paul M; Dickstein Y; Raz-Pasteur A
    Clin Microbiol Infect; 2016 Dec; 22(12):960-967. PubMed ID: 27283148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of antibiotics for treatment of inflammatory bowel disease.
    Nitzan O; Elias M; Peretz A; Saliba W
    World J Gastroenterol; 2016 Jan; 22(3):1078-87. PubMed ID: 26811648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of antimicrobial therapy in severe nosocomial infections: empiric choices, proportion of appropriate therapy, and adaptation rates--a multicentre, observational survey in critically ill patients.
    Vogelaers D; De Bels D; Forêt F; Cran S; Gilbert E; Schoonheydt K; Blot S;
    Int J Antimicrob Agents; 2010 Apr; 35(4):375-81. PubMed ID: 20122817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.